Correlation Between NeuroSense Therapeutics and Harrow Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NeuroSense Therapeutics and Harrow Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeuroSense Therapeutics and Harrow Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NeuroSense Therapeutics Ltd and Harrow Health, you can compare the effects of market volatilities on NeuroSense Therapeutics and Harrow Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeuroSense Therapeutics with a short position of Harrow Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeuroSense Therapeutics and Harrow Health.

Diversification Opportunities for NeuroSense Therapeutics and Harrow Health

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between NeuroSense and Harrow is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding NeuroSense Therapeutics Ltd and Harrow Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Harrow Health and NeuroSense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeuroSense Therapeutics Ltd are associated (or correlated) with Harrow Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Harrow Health has no effect on the direction of NeuroSense Therapeutics i.e., NeuroSense Therapeutics and Harrow Health go up and down completely randomly.

Pair Corralation between NeuroSense Therapeutics and Harrow Health

Assuming the 90 days horizon NeuroSense Therapeutics Ltd is expected to generate 7.01 times more return on investment than Harrow Health. However, NeuroSense Therapeutics is 7.01 times more volatile than Harrow Health. It trades about 0.27 of its potential returns per unit of risk. Harrow Health is currently generating about -0.05 per unit of risk. If you would invest  17.00  in NeuroSense Therapeutics Ltd on August 30, 2024 and sell it today you would earn a total of  13.00  from holding NeuroSense Therapeutics Ltd or generate 76.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy69.57%
ValuesDaily Returns

NeuroSense Therapeutics Ltd  vs.  Harrow Health

 Performance 
       Timeline  
NeuroSense Therapeutics 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in NeuroSense Therapeutics Ltd are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, NeuroSense Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Harrow Health 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Harrow Health are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Harrow Health may actually be approaching a critical reversion point that can send shares even higher in December 2024.

NeuroSense Therapeutics and Harrow Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NeuroSense Therapeutics and Harrow Health

The main advantage of trading using opposite NeuroSense Therapeutics and Harrow Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeuroSense Therapeutics position performs unexpectedly, Harrow Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harrow Health will offset losses from the drop in Harrow Health's long position.
The idea behind NeuroSense Therapeutics Ltd and Harrow Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities